Controlled release and bioactivity of the monoclonal antibody rituximab from a porous matrix: A potential in situ therapeutic device

S. Simovic, K.R. Diener, A. Bachhuka, K. Kant, D. Losic, J.D. Hayball, M.P. Brownc, K. Vasilev
  • Materials Letters, September 2014, Elsevier
  • DOI: 10.1016/j.matlet.2014.05.110

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Krishna Kant